For the Patient: SAAJAP

Similar documents
For the Patient: LUSCPE

For the Patient: LUPUPE

For the Patient: LUAVNP

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: LUSCTOP

For the Patient: LUAJPC

For the Patient: LUOTPAC

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: LUAVPP

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: ULUAVPMTN

ABOUT THIS MEDICATION

For the Patient: LUAVPG

For the Patient: LUAVPP (Carboplatin Option)

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: LUAVDC

For the Patient: Mitoxantrone Other names:

For the Patient: LUSCCAV

For the Patient: Methotrexate Other names: MTX

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: LULAPERT

For the Patient: GOOVCATM

For the Patient: GOOVCATR

For the Patient: GOOVDDCAT

For the Patient: LUAVPEM

For the Patient: GDP-R Other names: LYGDPR

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: GUBEP

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

ABOUT THIS MEDICATION

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: ACTW Other names: BRAJACTW

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

ABOUT THIS MEDICATION

For the Patient: GOCXCATB

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: Sunitinib Other names: SUTENT

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Olaparib tablets Other names: LYNPARZA

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: Lenalidomide Other names: REVLIMID

Treatment Plan: Drugs:

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

For the Patient: ACD

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

ABOUT THIS MEDICATION

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

GI = GastroIntestinal FIRINOX = Fluorouracil, Irinotecan, Infusional fluorouracil, Oxaliplatin

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

For the Patient: CAP. Capecitabine. Uses:

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

ABOUT THIS MEDICATION

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

For the Patient: GUPDOCADT

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: UMYLDREL

Docetaxel (Taxotere )

For the Patient: USMAVFIPI

INTENDED BENEFITS You are being asked to take these drugs as a treatment to reduce the risk of recurrence of cancer of the stomach or esophagus.

ABOUT THIS MEDICATION

5 Fluorouracil. Other Names: Adrucil. About This Drug. Possible Side Effects. Fluorouracil is used to treat cancer.it is given in the vein (IV).

Trastuzumab (Herceptin )

Transcription:

For the Patient: SAAJAP Other Names: Adjuvant Treatment of Osteosarcoma with Doxorubicin and Cisplatin SA = SArcoma AJ = AdJuvant A = Doxorubicin (ADRIAMYCIN ) P = CisPlatin ABOUT THIS MEDICATION What are these drugs used for? SAAJAP is an intravenous (through the vein) drug treatment for Osteosarcoma. It is used for patients with localized osteosarcoma to prevent metastases. The goal of this treatment is to prevent spread of the cancer (metastases) in patients with localized osteosarcoma. This treatment is offered to people who have good kidney function and a good performance status. Performance status is a measure of how well a person is able to perform their usual daily activities. How do these drugs work? Doxorubicin is an anticancer drug that works by interfering with the synthesis of DNA and RNA that are needed for cancer cells to divide. Cisplatin is an anticancer drug that works by preventing the synthesis of DNA, RNA and proteins that are needed for cancer cells to divide. INTENDED BENEFITS This treatment is being given to destroy and/or limit the growth of cancer cells that may have spread from the bone tumor to other parts of your body. This treatment may improve your current symptoms, and delay or prevent new symptoms from starting. It is not given to replace surgery which is the best way to cure osteosarcoma; it can however, eliminate the appearance of metastases spread of the tumor for many patients. SAAJAP TREATMENT SUMMARY How are these drugs given? You will generally be admitted to a hospital unit to receive this treatment. You should bring all your medications that you take at home with you to the hospital. Your treatment plan consists of up to 6 therapy cycles. Each cycle lasts 3 weeks (21 days). BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 1/8

For each cycle, you will be given the two therapy medications intravenously (through the vein) on Day 1. - Doxorubicin is given first, and is given as an injection. - You will then be given extra fluids intravenously for several hours before cisplatin. This is to help flush out your kidneys and prevent any kidney problems. - Cisplatin is given intravenously over two hours (120 minutes). - Intravenous fluids will be continued for 12 hours after the cisplatin has been given. What will happen when I get my drugs? A blood test is also done before Day 1 of each cycle. The dose and timing of your therapy may be changed based on your blood test results and/or other side effects. Your intravenous will be started to give you fluids after you have been checked in. Your nurse will be reviewing with you the possible side effects of your therapy plan and how to manage them. It is a good idea to have someone with you at your first therapy. You will be given anti-nausea medications by mouth and by vein to prevent nausea due to the drugs. You will be in hospital overnight so you can be observed after the treatment. On discharge from the hospital unit, you will be given prescriptions for anti-nausea medications. Fill these prescriptions at your regular pharmacy. Your nurse will tell you when to take the anti-nausea medication. It is easier to prevent nausea than to treat it once it happens, so follow the directions closely. SAAJAP TREATMENT PROTOCOL Start Date: Cycle 1: Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Blood Test Doxorubicin, Cisplatin Chemo Chemo Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 This 21-day cycle will be repeated 5 more times. Generally 3 cycles are given before surgery and 3 after surgery. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 2/8

CHEMOTHERAPY SIDE EFFECTS AND MANAGEMENT Are there any risks? Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of. SERIOUS SIDE EFFECTS Your white blood cells will decrease after your treatment. They usually return to normal within 3 weeks. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. Your platelets may decrease after your treatment. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. Doxorubicin and cisplatin burn if they leak under the skin. How Common Is It? Very Common Common Rare MANAGEMENT To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth by gently washing regularly. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100 F or 38 C by an oral thermometer), chills, cough or burning when you pass urine. To help prevent bleeding problems: Try not to bruise, cut or burn yourself. Clean your nose by blowing gently, do not pick your nose. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Avoid taking ASA (eg: ASPIRIN ) or Ibuprofen (eg: ADVIL ), unless prescribed by your doctor. Tell your nurse or doctor immediately if you feel burning, stinging, or any other change while the drugs are being given. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 3/8

SERIOUS SIDE EFFECTS Allergic reactions to cisplatin may rarely occur. Signs of an allergic reaction are dizziness, confusion and wheezing. This reaction may occur immediately or several hours after receiving cisplatin. This reaction can occur after the first dose of cisplatin or after many doses of cisplatin. How Common Is It? Rare MANAGEMENT Tell your nurse if this happens while you are receiving cisplatin or contact your oncologist immediately or get immediate emergency help if this happens after you leave the clinic. OTHER SIDE EFFECTS Nausea and vomiting may occur after your treatment. It usually improves after 48 hours but may linger for 5 7 days after treatment for some patients (i.e. delayed nausea and vomiting). How Common Is It? Very Common MANAGEMENT You will be given a prescription for anti-nausea drug(s) to take before your therapy treatment and/or at home. It is easier to prevent nausea than to treat it once it has happened, so follow directions closely. Drink plenty of liquids. Eat and drink often in small amounts. Try the ideas in Food Choices to Control Nausea. Your doctor may manage delayed nausea and vomiting differently. Be sure to let your doctor know if you experience this. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 4/8

Hair loss is common and may begin within a few days or weeks of treatment. Your hair may thin or you may become totally bald. Your scalp may feel tender. You may lose hair on your face and body. Your hair will grow back once your treatments are over and sometimes between treatments. Colour and texture may change. Sore mouth may occur a few days after treatment. Mouth sores can occur on the tongue, the sides of the mouth or in the throat. Mouth sores or bleeding gums can lead to an infection. Very Common Use a gentle shampoo and soft brush. Care should be taken with use of hair spray, bleaches, dyes, and perms. Protect your scalp with a hat, scarf or wig in cold weather. Cover your head or apply sunblock on sunny days. Apply mineral oil to your scalp to reduce itching. If you lose your eyelashes and eyebrows, protect your eyes from dust and grit with a broad-rimmed hat and glasses. Common Brush your teeth gently after eating and at bedtime with a very soft toothbrush. If your gums bleed, use gauze instead of a brush. Use baking soda instead of toothpaste. Make a mouthwash with ½ teaspoon baking soda or salt in 1 cup warm water and rinse several times a day. Try soft, bland foods like puddings, milkshakes and cream soups. Avoid spicy, crunchy or acidic food, and very hot or cold foods. Call your doctor if you are having difficulty eating or drinking due to pain. Try the ideas in Food Ideas for a Sore Mouth during Chemotherapy Diarrhea may occur. Common To help diarrhea: Drink plenty of liquids. Eat and drink often in small amounts. Avoid high fibre foods as outlined in Food Ideas to Help with Diarrhea. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 5/8

Loss of appetite and weight loss are common and may persist after your treatments are over. Pain or tenderness may occur where the needle was placed in your vein. Your skin may darken in some areas such as your nails, soles or palms. Common Try ideas in High Energy High Protein Ideas and in Healthy Eating Using High Energy, High Protein Foods. Uncommon Apply cool compresses or soak in cool water for 15-20 minutes several times a day. Uncommon This will slowly return to normal once you stop treatment. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 6/8

INSTRUCTIONS FOR THE PATIENT What other drugs can interact with SAAJAP? Other drugs such as some antibiotics given by vein (e.g., tobramycin, vancomycin), furosemide (LASIX ), phenytoin (DILANTIN ), pyridoxine, digoxin (LANOXIN ), warfarin (COUMADIN ) and cyclosporine (NEORAL or SANDIMMUNE ) may interact with SAAJAP. Tell your doctor if you are taking these or other drugs as you may need extra blood tests, your dose may need to be changed or your treatment may need to be held for a few days. Check with your doctor or pharmacist before you start taking any new prescription or non-prescription drugs. Other important things to know: Heart failure: rarely, doxorubicin can have a serious effect on the heart, causing failure of the heart s pumping action, which results in shortness of breath, fatigue and leg swelling. Your treatment may be stopped or interrupted if there are concerns about your heart function. Tell your doctor if you have ever had an unusual or allergic reaction to daunorubicin, epirubicin, idamycin, mitomycin or mitoxantrone before treatment begins. Your urine may be pink or reddish for 1-2 days after your treatment. This is expected as doxorubicin is red and is passed in your urine. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of this treatment. Sometimes, the nerve which allows you to hear can be affected by cisplatin. As a result, you may experience tinnitus (ringing in the ears) or a change in your hearing. Report any of these problems to your doctor and/or nurse. Cisplatin can cause changes in kidney function, but this is not frequent with the doses used in this type of treatment. It is important that you are well-hydrated before and after treatment. Following your treatment, your doctor may ask you to drink plenty ofliquids (8-12 cups a day) to prevent kidney problems. Report any signs of kidney problems such as lower back or side pain, swelling of feet or lower legs to your doctor as soon as possible. This treatment will interfere with menstrual cycle and less commonly may cause sterility in men and menopause in women. If you plan to have children, discuss this with your doctor before starting treatment. This treatment may damage sperm and may cause harm to the baby if used during pregnancy. It is best to use birth control while you are undergoing treatment. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Tell all doctors or dentists you see that you are being treated with doxorubicin and cisplatin before you receive treatment of any form. BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 7/8

SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of an infection such as fever (over 100 F or 38 C by an oral thermometer); chills; cough; pain or burning when you pass urine. Signs of bleeding problems such as black, tarry stools; blood in urine; pinpoint red spots on skin; extensive bruising. Signs of an allergic reaction (rare) soon after a treatment including dizziness, fast heartbeat, face swelling or breathing problems. Signs of heart problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath or difficulty breathing, swelling of ankles or fainting. Signs of a stroke such as sudden onset of: severe headache, eyesight changes, slurred speech, loss of coordination, weakness or numbness in arm or leg. Signs of a blood clot such as tenderness or hardness over a vein, calf swelling and tenderness, sudden onset of cough, chest pain or shortness of breath. Seizures or loss of consciousness. SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Muscle weakness. Signs of anemia such as unusual tiredness or weakness. Signs of gout such as joint pain. Changes in eyesight. Signs of kidney problems such as lower back or side pain, swelling of feet. Uncontrolled nausea, vomiting, or diarrhea. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE TO BOTHER YOU: Easy bruising or bleeding. Redness, swelling, pain or sores where the needle was placed. Redness, swelling, pain or sores on your lips, tongue, mouth or throat. Ringing in your ears or hearing problems. Sings of anemia such as unusual tiredness or weakness. Skin rash or itching. Numbness or tingling in feet or hands or painful leg cramps. If you experience symptoms or changes in your body that have not been described above but worry you, or if any symptoms are severe, contact: at telephone number BC Cancer Agency Protocol Summary (Patient Version) SAAJAP 8/8